Imaging and therapy with rituximab anti-CD20 immunotherapy in an animal model of central nervous system lym phoma

被引：0
|
作者：
Muldoon, Leslie L. [1 ]
Lewin, Seth J. [1 ]
Dosa, Edit [1 ]
Pagel, Michael A. [1 ]
Doolittle, Nancy D. [1 ]
Neuwelt, Edward A. [1 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-5529
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5529
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Low-dose Subcutaneous Anti-CD20 Therapy Effectively Depletes B Cells and Ameliorates Central Nervous System Autoimmunity
    Smith, Paul
    Huck, Catherine
    Wegert, Vanessa
    Schmid, Cindy
    Dunn, Robert
    Leppert, David
    Wallstroem, Erik
    NEUROLOGY, 2017, 88
  • [22] Systemic administration of anti-CD20 indirectly reduces B cells in the inflamed meninges in a chronic model of central nervous system autoimmunity
    Tesfagiorgis, Yodit
    Kemal, Eden A.
    Craig, Heather C.
    Parham, Kate A.
    Kerfoot, Steven M.
    JOURNAL OF NEUROIMMUNOLOGY, 2024, 387
  • [23] Systemic administration of anti-CD20 indirectly reduces B cells in the inflamed meninges in a chronic model of central nervous system autoimmunity
    Kerfoot, Steven
    Tesfagiorgis, Yodit
    Kemal, Eden A.
    Craig, Heather C.
    Parham, Kate A.
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01)
  • [24] Successful treatment with anti-CD20 monoclonal antibody (rituximab) of life-threatening refractory systemic lupus erythematosus with renal and central nervous system involvement
    Saito, K
    Nawata, M
    Nakayamada, S
    Tokunaga, M
    Tsukada, J
    Tanaka, Y
    LUPUS, 2003, 12 (10) : 798 - 800
  • [25] Anti-CD20 Therapy in NOD Model of Type 1 Diabetes
    Hu, Changyun
    Rodriguez, Daniel
    Du, Wei
    Ahuja, Anupama.
    Wong, F. Susan
    Shlomchik, Mark
    Wen, Li
    JOURNAL OF IMMUNOLOGY, 2007, 178
  • [26] Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infection
    Browne, Sarah K.
    Zaman, Rifat
    Sampaio, Elizabeth P.
    Jutivorakool, Kamonwan
    Rosen, Lindsey B.
    Ding, Li
    Pancholi, Minjal J.
    Yang, Lauren M.
    Priel, Debra Long
    Uzel, Gulbu
    Freeman, Alexandra F.
    Hayes, Carlton E.
    Baxter, Roger
    Cohen, Stuart H.
    Holland, Steven M.
    BLOOD, 2012, 119 (17) : 3933 - 3939
  • [27] Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis Is Intrathecal Anti-CD20 a Therapeutic Option?
    Fereidan-Esfahani, Mahboobeh
    Brueck, Wolfgang
    Weber, Martin S.
    JAMA NEUROLOGY, 2015, 72 (12) : 1407 - 1408
  • [28] Fatal underhanded chronic enterovirus infection associated with anti-CD20 monotherapy for central nervous system demyelinating disease
    Luciani, Lea
    Ninove, Laetitia
    Zandotti, Christine
    Chalvignac, Virginie
    Lagier, David
    Baume, Julien
    Melade, Julien
    Piorkowski, Geraldine
    Coutard, Bruno
    Lepidi, Hubert
    Pelletier, Jean
    Audoin, Bertrand
    Rico-Lamy, Audrey
    Nougairede, Antoine
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (02) : 320 - 323
  • [29] Anti-CD20 monoclonal antibody (rituximab) therapy in a child with refractory chronic autoimmune haemolytic anaemia
    Kerridge, I
    Hann, I
    Ethel, M
    Potter, M
    Prentice, HG
    INTERNAL MEDICINE JOURNAL, 2003, 33 (11) : 544 - U3
  • [30] Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: A case report
    Aranda, JM
    Scornik, JC
    Normann, SJ
    Lottenberg, R
    Schofield, RS
    Pauly, DF
    Miles, M
    Hill, JA
    Sleasman, JW
    Skoda-Smith, S
    TRANSPLANTATION, 2002, 73 (06) : 907 - 910
12345